Bill
Bill > S3733
NJ S3733
NJ S3733Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
summary
Introduced
03/20/2023
03/20/2023
In Committee
03/20/2023
03/20/2023
Crossed Over
Passed
Dead
01/08/2024
01/08/2024
Introduced Session
2022-2023 Regular Session
Bill Summary
Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
AI Summary
This bill requires Medicaid coverage for ovulation enhancing drugs and related medical services for certain beneficiaries aged 21 through 44 years who are experiencing infertility, defined as the failure to establish a clinical pregnancy after a specified period of regular, unprotected sexual intercourse. The coverage is limited to three treatment cycles per lifetime of the beneficiary. The bill also directs the Commissioner of Human Services to apply for necessary state plan amendments or waivers to implement the provisions and secure federal financial participation, and to adopt implementing rules and regulations.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 03/20/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2022/S3733 |
| BillText | https://pub.njleg.gov/Bills/2022/S4000/3733_I1.HTM |
Loading...